Related Experiment Video
Updated: Aug 15, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
[Anti-fungal drugs. Current status and guidelines for their administration]
Rodrigo Fernández Alonso1, Maria Esther González García, Joaquín Fernández García
1Servicio de Microbiología, Hospital Vall d'Hebrón, Barcelona, Spain.
Abstract:
Current medicine, in its zeal to cure diseases that, to-date, have been incurable, has overcome many barriers. High-dose chemotherapy, bone marrow and solid organ transplant, haemodialysis, parenteral and enteral nutrition, and other techniques have produced longer survival and cures for seriously ill patients. Over the past few years, fungal infections have become an important factor in morbidity and mortality in patients who are not only immunocompromised but also suffering severe pathologies. Anti-fungal treatment has been enriched, recently, with new compounds that are widening the therapeutic options for many of these patients.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Anthelminthic Agents
Antiprotozoal Agents

